Brian Daniel Webster Insider Trades & Stock Holdings

President and Chief Executive Officer · Kestra Medical Technologies, Ltd. · Latest filing Oct 20, 2026

Brian Daniel Webster, President and Chief Executive Officer at Kestra Medical Technologies, Ltd. has 2 Form 4 trades on file since Jul 15, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($780K), net -$780K. Latest filing: disposed of 15K shares of $KMTS on Oct 20, 2026 at $29.56.

Trades on file
2
Open-market bought
$0
Open-market sold
$780K
Net open-market
-$780K
Shares held ($KMTS)
445.21K
Latest filing
Oct 20, 2026

Shares held by Brian Daniel Webster

Shares owned after the most recent Form 4 for each company.

All insider trades by Brian Daniel Webster

DateTicker TypeSharesPriceValue Owned afterΔOwn 1W1M6MRoleFilingStory
$KMTS Sell (Open-market sale) 10b5-1 15K $29.56 $443.39K 445.21K -3.26% President and Chief Executive Officer SEC Read
$KMTS Sell (Open-market sale) 10b5-1 15K $22.44 $336.61K 556.94K -2.62% -15.1%+13.9% President and Chief Executive Officer SEC —

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Brian Daniel Webster traded

Frequently asked questions

Has Brian Daniel Webster been buying or selling stock?

Brian Daniel Webster has 0 open-market purchases and 2 open-market sales on file, net -$780K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Brian Daniel Webster's latest insider trade?

disposed of 15K shares of $KMTS on Oct 20, 2026 at $29.56.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text

SMS Terms

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Full terms and conditions